Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

19.97 +0.65 (+3.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Why Amarin Fell Again Today
Another Vascepa generic is launched in the U.S. 
Via The Motley Fool
Topics Intellectual Property
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises 1.5%; Tarsus Pharmaceuticals Shares Slide
Midway through trading Monday, the Dow traded up 1.48% to 33,782.47 while the NASDAQ rose 0.74% to 14,134.01. The S&P also rose, gaining 1.17% to 4,215.39. The U.S. has the... 
Via Benzinga
Topics Stocks
31 Stocks Moving In Monday's Mid-Day Session
Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)... 
Via Benzinga
Why Amarin Stock Is Sinking Today
The biotech's attempt to revive Vascepa's U.S. patent protection appears to be at a dead end. 
Via The Motley Fool
Topics Intellectual Property
Understanding Amarin Corp's Unusual Options Activity
Amarin Corp (NASDAQ:AMRN) shares experienced unusual options activity on Wednesday. The stock price moved up to $5.02 following the option alert. Sentiment: BEARISH Option Type... 
Via Benzinga
Market Briefing For Tuesday, Jun. 8
Benign market behavior generally persists; as an out-of-the-box rally effort to start Monday was reversed, as is typical since traders want a pullback first. 
Via Talk Markets
Why Amarin Trounced the Market on Tuesday
Investors reacted positively to a company presentation at an industry convention. 
Via The Motley Fool
Why Amarin Stock Is Tumbling Today
An analyst downgraded the drugmaker. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2021
Upgrades Craig-Hallum upgraded the previous rating for ShotSpotter Inc (NASDAQ:SSTI) from Hold to Buy. For the first quarter, ShotSpotter had an EPS of $0.02, compared to... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
HC Wainwright & Co. lowered Novavax, Inc. (NASDAQ: NVAX) price target from $317 to $294. Novavax shares fell 1.6% to $136.00 in pre-market trading. Needham cut BigCommerce... 
Via Benzinga
Amarin (AMRN) Q1 2021 Earnings Call Transcript
AMRN earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Amarin: Q1 Earnings Insights
Shares of Amarin Corp (NASDAQ:AMRN) rose 2.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 100.00% over the past... 
Via Benzinga
Cramer Weighs In On Paysafe, Xilinx And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Keysight Technologies Inc (NYSE: KEYS) has been just red hot and he really likes it. Amarin Corporation plc (... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers NovoCure (NASDAQ:NVCR) shares rose 42.08% to $187.38 during Tuesday's regular session. Trading volume for NovoCure's stock is 11.4 million as of 12:32 EST... 
Via Benzinga
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
Why Amarin Stock Is Sinking Today
The company's CEO announced his retirement. 
Via The Motley Fool
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Should You Buy Amarin in April?
This biotech's heart medication could be wildly lucrative. 
Via The Motley Fool
50 Biggest Movers From Yesterday
Gainers Mackinac Financial Corporation (NASDAQ: MFNC) shares surged 60.7% to close at $21.16 on Tuesday after the company, and Nicolet Bankshares, jointly announced the execution... 
Via Benzinga
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life Sciences Corp. (... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.